Comment on “The pros and cons of continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin”. Authors’ reply

Excerpt

We are grateful to Dr. Frontino and colleagues for their comments [1] and interest in our work [2]. We acknowledge that type 1 diabetic patients treated with multiple daily injections (MDI) of insulin using continuous glucose monitoring (CGM) may benefit from the use of glucose rate of change (ROC) arrows to make insulin dose adjustments. ROC arrows indicate the direction and velocity of changing glucose, reflecting a combination of recent glucose readings. However, at least three glycemic measurements in the last 15 min are required to describe the glycemic trend. In order to make safe therapeutic decisions, the information on the velocity of changing glucose should be integrated with that coming from the trend graph and glycemic measurements by self-blood glucose monitoring. …